KTTA logo

Pasithea Therapeutics Corp.

KTTA
Healthcare|Biotechnology|US
$0.58
+0.06 (+11.31%)
DCF Value
$7.85
Tangible Book / Share
$6.60
Cash / Share
$6.49
Next Earnings Report
Nov 12, 2026
EPS est. -$0.21 · Revenue est. $200.0K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Dec 1, 2025 (424B4). Possible dilution.

Upcoming Data Readouts (2)

Sep 2027
Est. completion
P1RAS Mutation
PAS-004 in Patients With Advanced Solid Tumors
NCT06299839n=83
Feb 2028
Est. completion
P1NF1 Mutation
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
NCT06961565n=56

Recent Press Releases

Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF)
Nov 3, 2026 · GlobeNewsWire
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
Oct 28, 2026 · GlobeNewsWire
Pasithea Therapeutics Announces Positive PAS-004 Clinical Data from Phase 1 Advanced Cancer Study Presented at ESMO Congress 2026
Oct 23, 2026 · GlobeNewsWire
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
Sep 14, 2026 · GlobeNewsWire
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
Sep 3, 2026 · GlobeNewsWire

SEC Filings (74)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Sep 16, 20268-KMaterial eventDocumentIndex
Sep 16, 202625-NSEDocumentIndex
Sep 9, 20268-KMaterial eventDocumentIndex
Aug 21, 20268-KMaterial eventDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 2026ARSAnnual report to holdersDocumentIndex
Aug 7, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 31, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 29, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jul 1, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 23, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
Apr 22, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 8, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Feb 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 20, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 30, 2026S-8Employee stock planDocumentIndex
Jan 28, 20268-KMaterial eventDocumentIndex
Jan 27, 2026EFFECTDocumentIndex
Jan 26, 2026POS AMDocumentIndex
Dec 29, 2025DEF 14AProxy / shareholder voteDocumentIndex
Dec 19, 2025PRE 14AProxy / shareholder voteDocumentIndex
Dec 15, 20258-KMaterial eventDocumentIndex
Dec 8, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 5, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 5, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 2, 20258-KMaterial eventDocumentIndex
Dec 1, 2025424B4Offering prospectusDocumentIndex
Nov 28, 2025EFFECTDocumentIndex
Nov 26, 2025S-1/AIPO / offering registrationDocumentIndex
Nov 25, 20258-KMaterial eventDocumentIndex